Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pancreatic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00558207
What this trial is testing

Phase 2 Study of ARQ 197 Versus Gemcitabine in Treatment-Naïve Patients With Unresectable Locally Advanced or Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Neoplasms
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 43
Early research (Phase 1)Looking for participantsNCT05877599
What this trial is testing

NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Who this might be right for
Non-small Cell Lung CancerHead and Neck Squamous Cell CarcinomaColorectal Carcinoma+5 more
AstraZeneca 45
Testing effectiveness (Phase 2)Ended earlyNCT01413087
What this trial is testing

Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreas, Adenocarcinoma
Anchiano Therapeutics Israel Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT00398086
What this trial is testing

Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Celgene 67
Early research (Phase 1)Study completedNCT00925769
What this trial is testing

ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Hoffmann-La Roche 32
Testing effectiveness (Phase 2)UnknownNCT02135822
What this trial is testing

Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT01017822
What this trial is testing

Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT02843945
What this trial is testing

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

Who this might be right for
Pancreatic Cancer
CivaTech Oncology 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07578337
What this trial is testing

A Clinical Study Evaluating a New Treatment Strategy for Patients With Advanced Pancreatic Cancer Who Have Not Received Prior Treatment for Advanced Disease.

Who this might be right for
UntreatedAdvanced Pancreatic Cancer
Nelum Corp 40
Testing effectiveness (Phase 2)Study completedNCT00634751
What this trial is testing

CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma

Who this might be right for
Pancreatic NeoplasmsBile Duct Neoplasms
University of Wisconsin, Madison 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07825753
What this trial is testing

Protein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and Breast Cancer

Who this might be right for
Advanced or Metastatic Pancreatic AdenocarcinomaAdvanced or Metastatic Breast Cancer (BC)
Fudan University 225
Testing effectiveness (Phase 2)Active Not RecruitingNCT01824875
What this trial is testing

Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+4 more
ECOG-ACRIN Cancer Research Group 144
Not applicableAvailableNCT01786850
What this trial is testing

Magnetic Resonance-guided High-intensity Focused Ultrasound Treatment of Locally Advanced Pancreatic Cancer

Who this might be right for
PancreasCancerLocally Advanced Pancreatic Cancer+1 more
University of Roma La Sapienza
Testing effectiveness (Phase 2)Active Not RecruitingNCT06429904
What this trial is testing

Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Cancer
Peking Union Medical College Hospital 31
Early research (Phase 1)Study completedNCT06048367
What this trial is testing

Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor

Who this might be right for
Advanced Solid TumorLung CancerPancreas Cancer+6 more
Sichuan Enray Pharmaceutical Sciences Company 19
Testing effectiveness (Phase 2)Study completedNCT00111904
What this trial is testing

Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Theradex 43
Testing effectiveness (Phase 2)Ended earlyNCT03829501
What this trial is testing

A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies

Who this might be right for
Squamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Kymab Limited 222
Testing effectiveness (Phase 2)Active Not RecruitingNCT04205227
What this trial is testing

ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors

Who this might be right for
CancerMelanomaOvary Cancer+2 more
ENB Therapeutics, Inc 137
Testing effectiveness (Phase 2)Ended earlyNCT00831493
What this trial is testing

Vorinostat Plus Radiation Therapy in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Looking for participantsNCT07354919
What this trial is testing

Axelopran for Advanced Cancer in Patients Receiving Opioids

Who this might be right for
Breast CancerLung CancerPancreas Cancer+1 more
HealthPartners Institute 34
Next Page